Sensitive ASX Announcement

Vanderbilt Health to conduct clinical trial of HMBD-002

Published: 28/08/26, 08:11am (AEST)•3 pages
Percheron Therapeutics
PER:ASX•Healthcare

Recent PER Announcements

Price Sensitive only